Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
220.00    5.00 (2.33%)
Bid:
215.00
Ask:
225.00
Spread: 10.00 (4.651%)
Market Cap: £177.73m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

AGM Statement

Today 07:00

RNS Number : 3843I
Warpaint London PLC
16 June 2026
 

16 June 2026

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

AGM Statement

 

Warpaint London PLC (AIM: W7L), the specialist supplier of high-quality colour cosmetics and personal care brands at an affordable price, announces that at the Annual General Meeting ("AGM") of the Company to be held at 10 a.m. today, Clive Garston, Chairman of the Company, will make the following statement:

 

"As outlined in our 2025 full year results announcement at the end of April, the trading conditions experienced in 2025 continued in Q1 2026. While trading conditions continue to be difficult, Q2 so far has been more encouraging, with sales from 1 April to 31 May 2026 ahead of the same period last year. Pleasingly, Group sales overall continue to be achieved at an improved margin compared to that achieved in 2025.

 

"The Group has further significant planned expansion opportunities, particularly for later in 2026, and expects continued margin improvement. Therefore, whilst the Board is mindful of the ongoing macroeconomic headwinds and challenging trading conditions, expectations for the full year remain unchanged. 

 

"As previously indicated, sales in 2026 are expected to be more second half weighted than prior years due to the timing of certain larger orders and planned customer rollouts. These include Dirk Rossmann in Germany, which launched, as expected, a capsule range of W7 products into 2,200 of its stores in May 2026 and early sales are encouraging. In the US, in addition to the previously announced significantly improved Christmas order received from Walmart, the Group will be launching an online Christmas gift range with Ulta Beauty, the largest specialty beauty retailer in the US, which may lead to further opportunities in 2027.

 

"The Company continues to have a strong balance sheet, with no debt. Cash balances as at 31 May 2026 totaled £20.6 million (31 May 2025: £15.0 million).

 

"As previously announced, pending approval by shareholders at today's AGM, a final dividend of 9.0 pence per share will be paid on 3 July 2026 to shareholders on the register at 12 June 2026."

 

Ward & Hagon Contract Renewal and Directorate Change

 

On 1 February 2024, the Company announced that it had renewed its contract with Ward & Hagon Management Consulting LLP ("Ward & Hagon") for a period of 24 months, with a continuation on the same terms thereafter until relevant notice is given. The Company is in advanced discussions with Ward & Hagon regarding a further renewal of this contract and an update to the arrangements, with extra services also being provided, with the objective of accelerating Warpaint's growth and driving business transformation (the "Renewal"). The Renewal is expected to include additional sales responsibilities and increased time commitments to reflect the increase in the size of the Warpaint business since 1 February 2024, both organically and with the acquisitions of Brand Architekts and the Barry M brand.

 

As part of the Renewal, Paul Hagon will step down from the board and therefore the resolution to approve his re-appointment will be withdrawn from the business of the AGM today.

 

The Company will make a further announcement in due course, as appropriate, regarding the Renewal.

 

Note: All figures used in this announcement are unaudited.

 

Enquiries:

 

Warpaint

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

c/o IFC

Shore Capital (Nominated Adviser & Joint Broker)

Patrick Castle, Daniel Bush, Lucy Bowden - Corporate Advisory

Fiona Conroy - Corporate Broking

 

020 7408 4090

Berenberg (Joint Broker)

Clayton Bush, Alix Mecklenburg-Solodkoff, Alex Wright

020 3207 7800

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Staton

020 3934 6632

 

 

Warpaint London PLC

 

Warpaint is a specialist supplier of high-quality colour cosmetics and personal care brands at an affordable price, sold under the W7, Technic, Skin & Tan, Super Facialist, Dirty Works and Fish Soho brands. Its brands are sold primarily to major retailers, retail chains and supermarkets, with a growing direct online business. Additionally, in February 2026, Warpaint acquired the Barry M colour cosmetic brand.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMAKPBNKBKBAAD
Date   Source Headline
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing
27th Jun 202211:34 amRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
31st May 20227:00 amRNSNotice of AGM and Posting of Annual Report
26th Apr 20223:57 pmRNSDividend Timetable
26th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12th Apr 20227:00 amRNSTrading Update and Notice of Results
21st Mar 20221:21 pmRNSHolding(s) in Company
11th Mar 20225:23 pmRNSPMDR / PCA Dealing
2nd Mar 20227:00 amRNSWard & Hagon Contract Renewal and Grant of Options
28th Feb 20224:29 pmRNSHolding(s) in Company
23rd Feb 20224:56 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSFull Year Trading Update
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSInterim Results
16th Sep 202112:16 pmRNSPrice Monitoring Extension
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSNotice of Results & Investor Webinar
3rd Aug 20217:00 amRNSAppointment of Non-Executive Director
11th Jun 202111:24 amRNSResult of AGM
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSAGM Statement
28th May 202111:01 amRNSTotal Voting Rights
25th May 20213:28 pmRNSGrant of Options and Director/PDMR Shareholding
17th May 202112:34 pmRNSNotice of AGM and Posting of Annual Report
6th May 20213:57 pmRNSExercise of share options, issue of equity and TVR
28th Apr 20217:00 amRNSResults for the year ended 31 December 2020
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSTrading Update and Notice of Results
19th Apr 20212:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.